DNA sequencing validation of Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid tests

American Journal of Clinical Pathology

Volumn 129, Issue 6, 2008, Pages 852-859

  Lee, Sin Hang ^a,b   Vigliotti, Veronica S ^a   Pappu, Suri ^a  

^a Milford Hospital   (United States)

^b NONE   (United States)

Author keywords

Chlamydia trachomatis DNA; Cryptic plasmid DNA; DNA sequencing validation; Gonococcal opa genes; Neisseria gonorrhoeae DNA; Nucleic acid tests

Indexed keywords

BACTERIAL DNA; NUCLEIC ACID;

AMPLICON; ARTICLE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DNA PROBE; DNA SEQUENCE; HUMAN; LABORATORY DIAGNOSIS; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEIC ACID AMPLIFICATION; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; STRAIN IDENTIFICATION; UTERINE CERVIX CYTOLOGY; VALIDATION PROCESS; ANALYTICAL EQUIPMENT; CHLAMYDIASIS; GENETICS; GONORRHEA; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR GENETICS; PREDICTION AND FORECASTING; VALIDATION STUDY;

BASE SEQUENCE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DNA, BACTERIAL; FALSE NEGATIVE REACTIONS; GONORRHEA; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MOLECULAR SEQUENCE DATA; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; SEQUENCE ANALYSIS, DNA;

EID: 45949106092     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/Y2202RVCGRWW1RWB     Document Type: Article

References (23)

1. Centers for Disease Control and Prevention. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections, 2002. MMWR Morb Mortal Wkly Rep. 2002;51(RR15):1-27.
2. Altman DG, Bland JM. Diagnostic tests 2: predictive values. BMJ. 1994;309:102.
3. Castriciano S, Luinstra K, Jang D, et al. Accuracy of results obtained by performing a second ligase chain reaction assay and PCR analysis on urine samples with positive or near-cutoff results in the LCx test for Chlamydia trachomatis. J Clin Microbiol. 2002;40:2632-2634.
4. Gronowski AM, Copper S, Baorto D, et al. Reproducibility problems with the Abbott laboratories LCx assay for Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2000;38:2416-2418.
5. Peterson EM, Darrow V, Blanding J, et al. Reproducibility problems with the AMPLICOR PCR Chlamydia trachomatis test. J Clin Microbiol. 1997;35:957-959.
6. Mulcahy GM, Albanese EA, Bachl BL. Reproducibility of the Roche Amplicor polymerase chain reaction assay for detection of infection by Chlamydia trachomatis in endocervical specimens. Clin Chem. 1998;44:1575-1578.
7. Culler EE, Caliendo AM, Nolte FS. Reproducibility of positive test results in the BDProbeTec ET system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2003;41:3911-3914.
8. Katz AR, Effler PV, Ohye RG, et al. False-positive gonorrhea test results with a nucleic acid amplification test: the impact of low prevalence on positive predictive value. Clin Infect Dis. 2004;38:814-819.
9. Farrel DJ. Evaluation of AMPLICOR Neisseria gonorrhoeae PCR using cppB nested PCR and 16S rRNA PCR. J Clin Microbiol. 1999;37:386-390.
10. Lum G, Garland SM, Tabrizi S, et al. Supplemental testing is still required in Australia for samples positive for Neisseria gonorrhoeae by nucleic acid detection tests. J Clin Microbiol. 2006;44:4292-4294.
11. Drake C, Barenfanger J, Lawhorn J, et al. Comparison of Easy-Flow Copan Liquid Stuart's and Starplex Swab transport systems for recovery of fastidious aerobic bacteria. J Clin Microbiol. 2005;43:1301-1303.
12. Lee SH, Vigliotti VS, Vigliotti JS, et al. Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories. Infect Agent Cancer. 2007;2:11. doi:10.1186/1750-9378-2-11.
13. Gaydos CA, Quinn TC, Willis D, et al. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol. 2003;41:304-309.
14. Martin DH, Nsuami M, Schachter J, et al. Use of multiple nucleic acid amplification tests to define the infected-patient "gold standard" in clinical trials of new diagnostic tests for Chlamydia trachomatis infections. J Clin Microbiol. 2004;42:4749-4758.
15. Jespersen DJ, Flatten KS, Jones MF, et al. Prospective comparison of cell cultures and nucleic acid amplification tests for laboratory diagnosis of Chlamydia trachomatis infections. J Clin Microbiol. 2005;43:5324-5326.
16. Whiley DM, Tapsall JW, Sloots TP. Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge. J Mol Diagn. 2006;8:3-15.
17. Dillon JR, Pauzé M. Relationship between plasmid content and auxotype in Neisseria gonorrhoeae isolates. Infect Immun. 1981;33:625-628.
18. Palmer HM, Mallinson H, Wood RL, et al. Evaluation of the specificities of five DNA amplification methods for the detection of Neisseria gonorrhoeae. J Clin Microbiol. 2003;41:835-837.
19. Hatt C, Ward ME, Clarke IN. Analysis of the entire nucleotide sequence of the cryptic plasmid of Chlamydia trachomatis serovar L1: evidence for involvement in DNA replication. Nucleic Acids Res. 1988;16:4053-4067.
20. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev. 1997;10:160-184.
21. Martin IM, Ison CA. Detection of mixed infection of Neisseria gonorrhoeae. Sex Transm Infect. 2003;79:56-58.
22. Tabrizi SN, Chen S, Tapsall J, et al. Evaluation of opa-based real-time PCR for detection of Neisseria gonorrhoeae. Sex Transm Dis. 2005;32:199-202.
23. Geraats-Peters CW, Brouwers M, Schneeberger PM, et al. Specific and sensitive detection of Neisseria gonorrhoeae in clinical specimens by real-time PCR. J Clin Microbiol. 2005;43:5653-5659.